Twitter

Posts Tagged ‘recurrent’


Therapy programs patients’ own cells to fight cancer

It is vanishingly rare for an experimental treatment to wipe out advanced, recurrent cancer, then keep the disease from coming back.

Read More...

Promising New Minimally Invasive, MRI-Guided Laser Treatment For Recurrent Glioblastoma

The first-in-human study of the NeuroBlate™ Thermal Therapy System finds that it appears to provide a new, safe and minimally invasive procedure for treating recurrent glioblastoma (GBM), a malignant type of brain tumor…

Read More...

New minimally invasive, MRI-guided laser treatment for brain tumor found to be promising in study

The first-in-human study of the NeuroBlate Thermal Therapy System finds that it appears to provide a new, safe and minimally invasive procedure for treating recurrent glioblastoma, a malignant type of brain tumor.

Read More...

New study of the molecular roots of recurrent bladder infections could lead to a vaccine

Urinary tract infections are the second most common bacterial infection in humans, and many of them are recurrent. A new study reveals the cellular and molecular basis of recurrent bladder infections and suggests possible treatment strategies, such as vaccines, to prevent this common problem.

Read More...

New study of the molecular roots of recurrent bladder infections could lead to a vaccine

Urinary tract infections are the second most common bacterial infection in humans, and many of them are recurrent. A new study reveals the cellular and molecular basis of recurrent bladder infections and suggests possible treatment strategies, such as vaccines, to prevent this common problem.

Read More...

Bevacizumab significantly improves survival for patients with recurrent and metastatic cervical cancer

Patients with advanced, recurrent, or persistent cervical cancer that was not curable with standard treatment who received the drug bevacizumab (Avastin) lived 3.7 months longer than patients who did not receive the drug, according to an interim analysis of a large, randomized clinical trial.

Read More...

Complete Remission Induced By Dendritic Cell Vaccine For Relapsed Neuroblastoma Patient

One year after his last treatment, a six-year-old boy with recurrent neuroblastoma is in complete remission for his high-risk metastatic cancer…

Read More...

Researchers discover new mutations driving malignant melanoma

Two new mutations that collectively occur in 71 percent of malignant melanoma tumors have been discovered in what scientists call the “dark matter” of the cancer genome, where cancer-related mutations haven’t been previously found. Reporting their findings in the Jan. 24 issue of Science Express, the researchers from Dana-Farber Cancer Institute and the Broad Institute said the highly “recurrent” mutations – occurring in the tumors of many people – may be the most common mutations in melanoma cells found to date.

Read More...

Researcher Leads Large Multicenter Gene Sequencing Study Of Neuroblastoma

An extensive genomic study of the childhood cancer neuroblastoma reinforces the challenges in treating the most aggressive forms of this disease. Contrary to expectations, the scientists found relatively few recurrent gene mutation – mutations that would suggest new targets for neuroblastoma treatment…

Read More...

Common data determinants of recurrent cancer are broken, mislead researchers

In order to study the effectiveness or cost effectiveness of treatments for recurrent cancer, you first have to discover the patients in medical databases who have recurrent cancer. Unfortunately, the widely used algorithms to find these patients don’t work.

Read More...